Trial intelligence / Profile preview

MAL PDT for Acne Vulgaris in Dark Skin

NCT00673933Phase 2Completed

Sponsor
Photocure
Start
May 2008
Primary completion
Dec 2008
Modality
Light/Condition-Responsive Prodrugs
Countries
1
01

Overview

A Phase 2 trial of methyl aminolevulinate in acne vulgaris, sponsored by Photocure. Started May 2008; status: completed.

02

Drugs

methyl aminolevulinate
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on NCT00673933.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00673933.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call